Table 6.

The values of the conformation number and the volumes receiving greater than 2 Gy and greater than 5 Gy in percentage using XiO, Prowess, and KonRad TPSs.

	$V_{\mathit{\text{receiving}}2\mathit{\text{Gy}}}(\%)$			$V_{\mathit{\text{receiving}}5\mathit{\text{Gy}}}(\%)$			CN
Tumor Site	XiO	Prowess	KonRad	XiO	Prowess	KonRad	XiO	Prowess	KonRad
Low‐grade Glioma	63	49	90.87	53.14	42.5	69.09	0.7	0.65	0.73
Parotid Ccarcinoma	79.4	46	98.67	68.68	38	78.10	0.68	0.68	0.71
Pituitary Adenoma	84.7	39.4	91.14	71.89	32.4	73.41	0.7	0.75	0.68
Retinoblastoma	90.2	41	81.88	56.86	30.5	48.08	0.69	0.71	0.7
Parotid Carcinoma	73.6	29	79.31	63.08	25	58.26	0.69	0.81	0.71
High‐risk	86.8	14.3	92.17	76.63	12	77.02	0.73	0.74	0.76
Medulloblastoma
Low‐risk	84.4	11.8	95.86	75.20	9.4	84.03	0.68	0.68	0.69
Medulloblastoma
Nasolaboil RMS	79.6	24	88.97	47.35	13	53.19	0.7	0.6	0.72
Rhabdomyosarcoma (RMS)	76.9	42.9	74.85	74.71	40.7	69.07	0.68	0.7	0.69
Ependymoma	60.9	71	62.94	54.47	62	53.08	0.71	0.7	0.73
Maxillary Sarcoma	76.4	34.5	80.89	62.64	30	65.12	0.75	0.83	0.75
Mean	77.8	36.6	85	64.1	30.5	66.2	0.7	0.7	0.72
SD	9.3	16.8	10.5	10.1	15.6	11.7	0.02	0.07	0.03
F‐test		47.4			27.4			0.4
p‐value		0.0001			0.0001			0.59